MY141789A - Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same. - Google Patents

Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.

Info

Publication number
MY141789A
MY141789A MYPI20020143A MYPI20020143A MY141789A MY 141789 A MY141789 A MY 141789A MY PI20020143 A MYPI20020143 A MY PI20020143A MY PI20020143 A MYPI20020143 A MY PI20020143A MY 141789 A MY141789 A MY 141789A
Authority
MY
Malaysia
Prior art keywords
salts
preparation
same
acyclic nucleoside
phosphonate derivatives
Prior art date
Application number
MYPI20020143A
Other languages
English (en)
Inventor
Jong-Ryoo Choi
Tae-Kyun Kim
Seung-Joo Cho
Gyoung-Won Kim
Tae-Saeng Choi
Chung-Mi Kim
Yong-Zu Kim
Jeong-Min Kim
Kee-Yoon Roh
Dong-Gyu Cho
Jae-Hong Lim
Jae-Taeg Hwang
Woo-Young Cho
Hyun-Sook Jang
Chang-Ho Lee
Original Assignee
Lg Chem Investment Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chem Investment Ltd filed Critical Lg Chem Investment Ltd
Publication of MY141789A publication Critical patent/MY141789A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MYPI20020143A 2001-01-19 2002-01-16 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same. MY141789A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20010003087 2001-01-19

Publications (1)

Publication Number Publication Date
MY141789A true MY141789A (en) 2010-06-30

Family

ID=36241797

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20020143A MY141789A (en) 2001-01-19 2002-01-16 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.

Country Status (22)

Country Link
US (3) US7157448B2 (enExample)
EP (1) EP1358198B1 (enExample)
JP (1) JP3959348B2 (enExample)
KR (1) KR100441638B1 (enExample)
CN (1) CN100347185C (enExample)
AR (1) AR035933A1 (enExample)
AT (1) ATE478887T1 (enExample)
AU (1) AU2002230230B2 (enExample)
BR (1) BR0206165A (enExample)
CA (1) CA2433591C (enExample)
DE (1) DE60237429D1 (enExample)
DK (1) DK1358198T3 (enExample)
EG (1) EG24382A (enExample)
ES (1) ES2350197T3 (enExample)
MX (1) MXPA03006001A (enExample)
MY (1) MY141789A (enExample)
NZ (1) NZ526632A (enExample)
PL (1) PL212730B1 (enExample)
PT (1) PT1358198E (enExample)
RU (1) RU2266294C2 (enExample)
WO (1) WO2002057288A1 (enExample)
ZA (1) ZA200304181B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY141789A (en) 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
WO2002069900A2 (en) * 2001-03-01 2002-09-12 Conforma Therapeutics Corp. Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
WO2003037860A2 (en) 2001-10-30 2003-05-08 Conforma Therapeutics Corporation Purine analogs having hsp90-inhibiting activity
AU2003263644A1 (en) * 2002-09-26 2004-04-19 Lg Life Sciences Ltd. (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
US7138401B2 (en) 2003-09-18 2006-11-21 Conforma Therapeutics Corporation 2-aminopurine analogs having HSP90-inhibiting activity
KR20050062940A (ko) * 2003-12-19 2005-06-28 주식회사 엘지생명과학 디이소프로필((1-((2-아미노-6-할로-9ｈ-퓨린-9-일)메틸)사이클로프로필)옥시)-메틸포스포네이트의 새로운 제조방법
KR20050062944A (ko) * 2003-12-19 2005-06-28 주식회사 엘지생명과학 디이소프로필((1-((2-아미노-6-클로로-9ｈ-퓨린-9-일)메틸)사이클로프로필)옥시)-메틸포스포네이트의 새로운 제조방법
US20060052346A1 (en) * 2004-02-17 2006-03-09 Averett Devron R Nucleoside phosphonate derivatives useful in the treatment of HIV infections
KR101033290B1 (ko) * 2004-07-02 2011-05-09 주식회사 엘지생명과학 다이아이소프로필((1-(하이드록시메틸)-사이클로프로필)옥시)메틸포스포네이트의 새로운 제조 방법
EP1831235B1 (en) 2004-12-16 2013-02-20 The Regents of The University of California Lung-targeted drugs
CA2602257A1 (en) * 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
US7674018B2 (en) * 2006-02-27 2010-03-09 Illumination Management Solutions Inc. LED device for wide beam generation
US8434912B2 (en) * 2006-02-27 2013-05-07 Illumination Management Solutions, Inc. LED device for wide beam generation
GB0623493D0 (en) * 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
TWI384986B (zh) * 2007-01-17 2013-02-11 Lg Life Sciences Ltd 抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
EA019919B1 (ru) 2007-04-13 2014-07-30 Саузерн Рисерч Инститьют Способ подавления роста или метастазирования ангиогенез-зависимой опухоли
WO2008144672A1 (en) * 2007-05-21 2008-11-27 Illumination Management Solutions, Inc. An improved led device for wide beam generation and method of making the same
EP2326870B1 (en) * 2008-08-14 2017-01-25 Cooper Technologies Company Led devices for offset wide beam generation
WO2010065663A2 (en) * 2008-12-03 2010-06-10 Illumination Management Solutions, Inc. An led replacement lamp and a method of replacing preexisting luminaires with led lighting assemblies
CN102093422B (zh) 2009-12-10 2015-02-25 中国人民解放军军事医学科学院毒物药物研究所 无环核苷膦酸酯衍生物及其医药用途
CN102286026B (zh) * 2010-06-18 2014-07-02 中国人民解放军军事医学科学院毒物药物研究所 无环核苷酸类似物的盐及其晶型和药物组合物
FI2648701T3 (fi) 2010-12-10 2023-06-12 Sigmapharm Laboratories Llc Hyvin stabiileja adefovirdipivoksiilin koostumuksia
CN107312039B (zh) 2012-08-30 2019-06-25 江苏豪森药业集团有限公司 一种替诺福韦前药的制备方法
EP3401320B1 (en) 2013-03-15 2020-05-13 The Regents of the University of California Acyclic nucleoside phosphonate diesters for use in treating human papilloma virus, cervical intraepithelial neoplasia, anal intraepithelial neoplasia, or vulvar intraepithelial neoplasia
CN104119385B (zh) * 2014-07-24 2017-04-05 廖国超 核苷类似物的磷酸酯前药及其应用
RS63250B1 (sr) 2014-09-15 2022-06-30 Univ California Nukleotidni analozi
CN106432330B (zh) * 2015-08-11 2019-02-01 天津科伦药物研究有限公司 Lb80380药物的中间体化合物及其制备方法和用途
WO2017048956A1 (en) 2015-09-15 2017-03-23 The Regents Of The University Of California Nucleotide analogs
CN106977548A (zh) * 2016-01-19 2017-07-25 四川海思科制药有限公司 倍司福韦复合物及其制备方法和用途
CN107849074A (zh) * 2016-01-19 2018-03-27 四川海思科制药有限公司 一种核苷类似物的烷氧烷基酯前药及其应用
KR102623581B1 (ko) * 2016-07-18 2024-01-11 일동제약(주) 항바이러스성 약물의 오로트산염, 이의 제조 방법 및 상기 염을 포함하는 약제학적 조성물
CN108276443A (zh) * 2017-01-06 2018-07-13 米文君 一种新的化合物及其用途
KR102096144B1 (ko) * 2017-07-03 2020-04-01 주식회사 엘지화학 포스포네이트 뉴클레오사이드계 b형 간염 치료제 합성용 중간체 화합물의 연속식 제조방법
CN108997429B (zh) * 2018-07-27 2020-10-30 广州粤美医药科技有限公司 一种制备贝西福韦的方法
CN113735863A (zh) * 2021-09-29 2021-12-03 武汉九州钰民医药科技有限公司 Wee1抑制剂adavosertib的制备工艺
CN113880883A (zh) * 2021-11-11 2022-01-04 奥锐特药业股份有限公司 核苷类磷酸酯前药的制备方法
CN114560463B (zh) * 2022-03-23 2023-10-20 福州大学 一种核壳结构的氮掺杂碳壳包裹碳化钼核微米球材料的制备方法
CA3262284A1 (en) 2022-07-21 2024-01-25 Antiva Biosciences, Inc. Pharmaceutical compositions and forms for the treatment of human papillomavirus (HPV) infection and HPV-induced neoplasm

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1494321A (en) * 1974-08-08 1977-12-07 Ici Ltd Prostanoic acid derivatives
US5688778A (en) 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs
GB8922076D0 (en) 1989-09-28 1989-11-15 Beecham Group Plc Novel process
US5177104A (en) 1990-04-03 1993-01-05 E. R. Squibb & Sons, Inc. 6-α-hydroxy derivatives of mevinic acids
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
DK0465297T3 (da) * 1990-07-04 1996-02-19 Merrell Pharma Inc 9-Purinylphosphonsyre-derivater
ES2118069T3 (es) 1990-09-14 1998-09-16 Acad Of Science Czech Republic Profarmacos de fosfonatos.
DK0502690T3 (da) * 1991-03-05 2000-05-22 Ajinomoto Kk Cyclopropanderivat
US5817647A (en) 1993-04-01 1998-10-06 Merrell Pharmaceuticals Inc. Unsaturated acetylene phosphonate derivatives of purines
EP0632048B1 (en) 1993-06-29 2001-03-21 Mitsubishi Chemical Corporation Phosphonate-nucleotide ester derivatives
WO1995007919A1 (en) 1993-09-17 1995-03-23 Gilead Sciences, Inc. Method for dosing therapeutic compounds
WO1995022330A1 (en) 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
IT1270008B (it) 1994-09-23 1997-04-16 Ist Superiore Sanita Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
US5977061A (en) 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US5874577A (en) * 1996-04-03 1999-02-23 Medichem Research, Inc. Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof
US5877166A (en) 1996-04-29 1999-03-02 Sri International Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
US5922695A (en) * 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
US5935946A (en) 1997-07-25 1999-08-10 Gilead Sciences, Inc. Nucleotide analog composition and synthesis method
NZ502837A (en) 1997-08-15 2001-01-26 Medivir Ab Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV)
MY141789A (en) 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
DE60329375D1 (en) * 2002-03-15 2009-11-05 Univ Wayne State Neue 2-amino-9-((2-hydroxymethyl)cyclopropylidenmethyl)-purine als antivirale mittel
AU2003263644A1 (en) * 2002-09-26 2004-04-19 Lg Life Sciences Ltd. (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof

Also Published As

Publication number Publication date
DE60237429D1 (de) 2010-10-07
US7157448B2 (en) 2007-01-02
PL212730B1 (pl) 2012-11-30
ES2350197T3 (es) 2011-01-20
ATE478887T1 (de) 2010-09-15
KR20020062216A (ko) 2002-07-25
PL373670A1 (en) 2005-09-05
PT1358198E (pt) 2010-10-01
US7723319B2 (en) 2010-05-25
JP2004518675A (ja) 2004-06-24
KR100441638B1 (ko) 2004-07-23
US20040063668A1 (en) 2004-04-01
US20100004440A1 (en) 2010-01-07
EP1358198B1 (en) 2010-08-25
EP1358198A4 (en) 2008-03-05
ZA200304181B (en) 2004-10-06
AR035933A1 (es) 2004-07-28
CA2433591C (en) 2009-07-28
US7605147B2 (en) 2009-10-20
CA2433591A1 (en) 2002-07-25
MXPA03006001A (es) 2003-09-10
JP3959348B2 (ja) 2007-08-15
CN100347185C (zh) 2007-11-07
EP1358198A1 (en) 2003-11-05
WO2002057288A1 (en) 2002-07-25
CN1487949A (zh) 2004-04-07
BR0206165A (pt) 2004-02-03
EG24382A (en) 2009-04-05
RU2266294C2 (ru) 2005-12-20
RU2003125372A (ru) 2005-01-20
US20060293284A1 (en) 2006-12-28
HK1062017A1 (en) 2004-10-15
DK1358198T3 (da) 2010-10-04
NZ526632A (en) 2005-10-28
AU2002230230B2 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
MY141789A (en) Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
NZ609146A (en) Modified 4’-nucleosides as antiviral agents
TW200630344A (en) Tetracyclic indole derivatives as antiviral agents
JO2403B1 (en) Nickeloside derivatives antiviral
MY128463A (en) 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
NZ536734A (en) Spiroindolinepiperidine derivatives
YU52403A (sh) Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
IL160045A0 (en) Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
ES2322602T3 (es) Compuestos heterotetraciclicos condensados y su uso como inhibidor de polimerasa del vhc.
MY127718A (en) Dolastatin 10 derivatives.
IL176155A0 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
WO2002069903A3 (en) Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
HUT54981A (en) Process for producing acryloyl-substituted pyrrole derivatives and pharmaceutical compositions comprising same
WO2006027628A3 (en) Naphthalimide derivatives as antiviral agents
TR200103395T2 (tr) 13-metil eritromisin türevleri.
MY118004A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
WO2004029064A8 (en) (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
DE60105610D1 (en) Pyrazinonderivate
DE602005018972D1 (de) 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
BR0016937A (pt) Compostos tricìclicos e método de tratar herpesvìrus
EP1048655A4 (en) 1,2-DIHYDRO-2-OXOCHINOLINE DERIVATIVES
MXPA04002784A (es) Sales farmaceuticamente aceptables de 20(s)-camptotecinas.